Systemic lupus erythematosus (Q44376): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed label, description and/or aliases in pt-br, en |
||
| description / pt-br | description / pt-br | ||
O lúpus eritematoso sistêmico (LES) é uma doença clinicamente multissistêmica, de origem autoimune e caracterizada pela presença de autoanticorpos direcionados contra antígenos nucleares. As manifestações incluem erupção cutânea, artrite e fadiga, nefrite, transtornos neurológicos, anemia e trombocitopenia na forma mais grave do espectro da doença. | |||
| description / en | description / en | ||
Systemic lupus erythematosus (SLE) is a clinically multisystem disease, which is autoimmune in origin and is characterised by the presence of autoantibodies directed against nuclear antigens. Manifestations include rash, arthritis and fatigue, nephritis, neurological problems, anaemia and thrombocytopenia at the more severe end of the spectrum. | |||
Revision as of 11:48, 13 August 2026
Systemic lupus erythematosus (SLE) is a clinically multisystem disease, which is autoimmune in origin and is characterised by the presence of autoantibodies directed against nuclear antigens. Manifestations include rash, arthritis and fatigue, nephritis, neurological problems, anaemia and thrombocytopenia at the more severe end of the spectrum.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | 4A40.0 |
||
| English | Systemic lupus erythematosus |
Systemic lupus erythematosus (SLE) is a clinically multisystem disease, which is autoimmune in origin and is characterised by the presence of autoantibodies directed against nuclear antigens. Manifestations include rash, arthritis and fatigue, nephritis, neurological problems, anaemia and thrombocytopenia at the more severe end of the spectrum. |
